Literature DB >> 2742627

Comparison of the prognostic utility of VEPs and SEPs in comatose children.

M J Taylor1, E J Farrell.   

Abstract

Visual evoked potentials and somatosensory evoked potentials were recorded in 37 children in coma soon after admission and then repeatedly during coma and emergence from coma. Evoked potentials were graded in 4 categories, ranging from normal to absent, and then related to patient outcome. Somatosensory evoked potentials were reliable predictors of outcome, particularly if both the initial and early repeated somatosensory evoked potentials were considered. Visual evoked potentials were not as reliable predictors as somatosensory evoked potentials; however, the presence or absence of both was significantly related to outcome. These data are generally consistent with the adult literature. We suggest that somatosensory evoked potentials be the evoked potential of choice in evaluating the prognosis of comatose children.

Entities:  

Mesh:

Year:  1989        PMID: 2742627     DOI: 10.1016/0887-8994(89)90063-5

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

Review 1.  Are somatosensory evoked potentials the best predictor of outcome after severe brain injury? A systematic review.

Authors:  B G Carter; W Butt
Journal:  Intensive Care Med       Date:  2005-04-22       Impact factor: 17.440

Review 2.  Neurological intensive care in children.

Authors:  J Pfenninger
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 3.  Prognostic value of somatosensory evoked potentials in comatose children: a systematic literature review.

Authors:  Riccardo Carrai; Antonello Grippo; Silvia Lori; Francesco Pinto; Aldo Amantini
Journal:  Intensive Care Med       Date:  2010-04-27       Impact factor: 17.440

Review 4.  [Coma. The prognostic value of evoked potentials in patients after traumatic brain injury].

Authors:  M H Morgalla; J Bauer; R Ritz; M Tatagiba
Journal:  Anaesthesist       Date:  2006-07       Impact factor: 1.041

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.